“Reimagine the meaning of a cancer diagnosis”: Meet a market access lead at Johnson & Johnson
At the intersection of biology and technology, Johnson & Johnson Innovative Medicine is transforming the patient experience, breaking down barriers to access and addressing the leading causes of mortality today. Maren Gaudig, Senior Global Compound Market Access Lead, Cell Therapy, explains.